MediRita

Startup Company for Artificial Intelligence in the area of Drug Discovery
 

Who are we?

We aim at the healthy life of human being. 

We pursue for people to benefit from the new drugs.

We focus on artificial intelligence that accelerates the development of new drugs

that treat various diseases especially including rare diseases.

Multi-omics based whole-body simulation
New Drug development costs
Economy of a new drug
New Drug development period
New drug benefits
 

Article

제목
매체
​날짜
 

Team

YoungWoo Pae, Ph.D.

Co-Founder, Chief Executive Officer

Former IBM Executive for Watson

Expert Council, KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association)

Seung-Hyun Jin, Ph.D.

Co-Founder, Chief Science Officer

Ph.D. in Physics, KAIST

Former Assistant Professor, Seoul National University Hospital

HeungSoo Kim, Ph.D.

Director of Business Leader

Former industry-academy cooperation professor, Chungnam National Uni.

Advisor

Young Gyu Cho, Ph.D.

Executive Vice President /  CTO,

Y BIOLOGICS
Ph.D. in Life Science, POSTECH

Former Director of Research, HANDOK

JungWoo Woo

Software Engineer

HyeongHwan Kim

Software Engineer

 

Partners

 
 
Contact us

Tel: 02-890-0779

Fax: 02-890-0780

#803, ​8F, Mario Tower, 28, Digital-ro 30-gil, Guro-gu, Seoul, Republic of Korea

Directions

​Guro Digital Complex Station EXIT 3, Walk for 8 minutes

2018 Guro Demo Day (3)